A Real-World Analysis of the Safety and Efficacy of BCMA-Directed CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment

Habib, A., Ahmed, N., Khan, A. M., Chang, D., Paul, B., Shaikh, H., … Friend, R. (2024). A Real-World Analysis of the Safety and Efficacy of BCMA-Directed CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment. Blood, 144(Supplement 1), 2009–2009. https://doi.org/10.1182/blood-2024-208799